(Q73075286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

editorial

0 references

title

Treatment of Kawasaki disease: corticosteroids revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

J W Newburger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

411-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

Corticosteroids in the treatment of the acute phase of Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

High-dose intravenous gammaglobulin for Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

Treatment of Kawasaki disease with corticosteroid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

The immunopathogenesis and management of Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

Coronary artery dimensions may be misclassified as normal in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970160-5

10.1016/S0022-3476(99)70160-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10518072%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference